Regulation of integrin surface expression

Details for Australian Patent Application No. 2009283879 (hide)

Owner New York Blood Center, Inc.

Inventors Mitchell, W. Beau; Abyaneh, Mahmoud Yazdani; Chen, Amanda

Agent Pizzeys

Pub. Number AU-A-2009283879

PCT Pub. Number WO2010/022139

Priority 61/090,488 20.08.08 US

Filing date 19 August 2009

Wipo publication date 25 February 2010

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/022139 Priority application(s): WO2010/022139

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009283881-Vehicle rollover protection roof geometry and structure

2009283878-Prosthetic heart valve and delivery apparatus